SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy

por Gerlach, Magdalena M., Stelling-Germani, Anna, Wu, Cheuk Ting, Newrzela, Sebastian, Döring, Claudia, Vela, Visar, Müller, Anne, Hartmann, Sylvia, Tzankov, Alexandar
Publicado 2020

The IL‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma

por Hashwah, Hind, Bertram, Katrin, Stirm, Kristin, Stelling, Anna, Wu, Cheuk‐Ting, Kasser, Sabrina, Manz, Markus G, Theocharides, Alexandre P, Tzankov, Alexandar, Müller, Anne
Publicado 2019